Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3Breast Neoplasms 3Rectal Neoplasms 2Pain, Postoperative 2Neurotoxicity Syndromes 2Neoplasms 2Colonic Neoplasms 2Agnosia 2Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Brain Tumor 1Stomach Neoplasms 1Seizures 1Pulmonary Disease, Chronic Obstructive 1Prostatic Neoplasms 1Primary Immunodeficiency Diseases 1Paclitaxel-induced Neuropathy 1Myoma 1Mesothelioma 1Infections 1Head and Neck Neoplasms 1Epstein-Barr Virus Infections 1Brain Neoplasms 1Anesthesia 1

Interventions

Voriconazole 4Vancomycin 3Fluconazole 3Filgrastim 3Ciprofloxacin 3Caspofungin 3liposomal amphotericin B 2Trimethoprim, Sulfamethoxazole Drug Combination 2Therapeutics 2Piperacillin, Tazobactam Drug Combination 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Itraconazole 2Granulocyte Colony-Stimulating Factor 2Fosfomycin 2Daptomycin 2Cyclophosphamide 2Cefazolin 2Antibiotic Prophylaxis 2ziprasidone 1threonic acid 1telavancin 1soybean oil, phospholipid emulsion 1plerixafor 1monalizumab 1lime 1human papillomavirus vaccine, L1 type 16, 18 1fluorescein isothiocyanate-keyhole limpet hemocyanin 1fludarabine phosphate 1fish oil triglycerides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Infections × Magnesium Sulfate × Clear all
NCT02496676 2022-03-02

Magnesium Supplementation in People With XMEN Syndrome

National Institutes of Health Clinical Center (CC)

Phase 1/2 Completed
8 enrolled 7 charts

Primary Immunodeficiency Diseases, Infections, Neoplasms, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡